Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Thymoma 2Esophageal Neoplasms 2Endometrial Neoplasms 2Uterine Prolapse 1Prostatic Neoplasms 1Prostatic Diseases 1Precancerous Conditions 1Pelvic Organ Prolapse 1Ovarian Neoplasms 1Obesity, Morbid 1Myasthenia Gravis 1Menstruation Disturbances 1Mediastinal Neoplasms 1Leiomyoma 1Hernia, Ventral 1Hernia, Inguinal 1Genital Diseases, Female 1Endometriosis 1Colonic Neoplasms 1Adenomyosis 1

Interventions

Bevacizumab 27Leucovorin 23Fluorouracil 22Oxaliplatin 17Irinotecan 15Cetuximab 14pembrolizumab 11IFL protocol 11Panitumumab 10Folfox protocol 10Capecitabine 10Gemcitabine 7adagrasib 5Cisplatin 5Carboplatin 5Ramucirumab 4Colonoscopy 4veliparib 3spartalizumab 3selpercatinib 3regorafenib 3labetuzumab 3durvalumab 3conatumumab 3cemiplimab 3Pemetrexed 3Paclitaxel 3HMPL-013 3Drug Therapy 35,11-methenyltetrahydrohomofolate 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Colonic Neoplasms × Robotic Surgical Procedures × Clear all
NCT04403022 2026-06-03

da Vinci SP® Investigational Device Exemption Study in Colorectal Procedures

Intuitive Surgical

Phase NA Active not recruiting
60 enrolled 9 charts
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡